These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1145920)

  • 41. Inhibition of human mixed lymphocyte reaction by antibodies to immunoglobulin light chain determinants.
    Greaves MF; Torrigiani G; Roitt IM
    Clin Exp Immunol; 1971 Sep; 9(3):313-28. PubMed ID: 4105838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of lymphocyte blastogenesis by factor(s) in alloxan-diabetic rat plasma.
    Pallavicini MG; Nichols WK
    Diabetes; 1976 Jul; 25(7):614-22. PubMed ID: 179906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Antigenic" disparity between cultured lymphoid cells and autologous lymphocytes.
    Han T; Sokal JE; Moore GE
    Am J Med; 1972 Oct; 53(4):437-45. PubMed ID: 4263184
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum factor: the inhibition of phytohemagglutinin-induced blastogenesis of chronic lymphocytic leukemia lymphocytes.
    Monahan TM; Fritz RR; Abell CW
    J Natl Cancer Inst; 1976 Jul; 57(1):217-20. PubMed ID: 1003503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Studies on the cellular immune response in patients with bladder carcinoma. III. Inhibition of phytohemagglutinin-induced lymphocytes transformation by serum from the patients with bladder carcinoma (author's transl)].
    Nishio S
    Nihon Hinyokika Gakkai Zasshi; 1978 Mar; 69(3):347-56. PubMed ID: 661041
    [No Abstract]   [Full Text] [Related]  

  • 46. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.
    Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
    Invest Urol; 1979 Mar; 16(5):342-5. PubMed ID: 429128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. IV. Leucocyte adherence inhibition.
    Ablin RJ; Bhatti RA; Guinan PD; Bruns GR
    Urol Int; 1976; 31(6):459-69. PubMed ID: 795128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of leukocyte migration by serum from patients with prostatic cancer.
    Ablin RJ; Guinan PD; Bush IM; Bruns GR
    Allergol Immunopathol (Madr); 1975; 3(6):379-84. PubMed ID: 56882
    [No Abstract]   [Full Text] [Related]  

  • 50. Phylogeny of immunocompetent cells. I. In vitro blastogenesis and mitosis of toad (Bufo marinus) splenic lymphocytes in response to phytohemagglutinin and in mixed lymphocyte cultures.
    Goldshein SJ; Cohen N
    J Immunol; 1972 Apr; 108(4):1025-33. PubMed ID: 5023165
    [No Abstract]   [Full Text] [Related]  

  • 51. Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer.
    Ablin RJ
    Am J Reprod Immunol (1980); 1981 Aug; 1(4):206-9. PubMed ID: 7337156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphocyte activation. II. discriminating stimulation of lymphocyte subpopulations by phytomitogens and heterologous antilymphocyte sera.
    Janossy G; Greaves MF
    Clin Exp Immunol; 1972 Mar; 10(3):525-36. PubMed ID: 5033804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of cellular immunity in the human fetus: dichotomy of proliferative and cytotoxic responses of lymphoid cells to phytohemagglutinin.
    Stites DP; Carr MC; Fudenberg HH
    Proc Natl Acad Sci U S A; 1972 Jun; 69(6):1440-4. PubMed ID: 4504355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-mediated immune reactions to human tumors.
    Perlmann P; Troye M; Pape GR
    Cancer; 1977 Jul; 40(1 Suppl):448-57. PubMed ID: 69485
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro properties of leukocyte dialysates containing transfer factor.
    Ascher MS; Schneider WJ; Valentine FT; Lawrence HS
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1178-82. PubMed ID: 4524630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of antilymphocyte serum on the traffic of cells through the popliteal lymph node and on the antibody-forming cells produced within the node.
    Hay JB; Yamashita A; Morris B
    Lab Invest; 1974 Sep; 31(3):276-85. PubMed ID: 4607185
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro stimulation or inhibition of lymphocyte activation by antilymphocyte serum.
    Brochier J; Revillard JP
    Transplant Proc; 1971 Mar; 3(1):788-92. PubMed ID: 4999471
    [No Abstract]   [Full Text] [Related]  

  • 59. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.
    Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K
    Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240
    [No Abstract]   [Full Text] [Related]  

  • 60. Lymphocyte transformation induced by autologous cells. II. Stimulation by mitogen-induced lymphoblasts.
    Weksler ME
    J Exp Med; 1973 Mar; 137(3):799-806. PubMed ID: 4689338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.